Sodium cyanoborohydride → (3aR,7aS)-1-[1'-(2-methylbenzoyl)-1,4'-bipiperidin-4-yl]octahydro-2H-indol-2-one
反応式
Cl.[NH:2]1[CH2:7][CH2:6][CH:5]([N:8]2[C@@H:16]3[C@H:11]([CH2:12][CH2:13][CH2:14][CH2:15]3)[CH2:10][C:9]2=[O:17])[CH2:4][CH2:3]1.C[O-].[Na+].[CH3:21][C:22]1[CH:36]=[CH:35][CH:34]=[CH:33][C:23]=1[C:24]([N:26]1[CH2:31][CH2:30][C:29](=O)[CH2:28][CH2:27]1)=[O:25].C([BH3-])#N.[Na+]>CO.[Cl-].[Zn+2].[Cl-]>[CH3:21][C:22]1[CH:36]=[CH:35][CH:34]=[CH:33][C:23]=1[C:24]([N:26]1[CH2:27][CH2:28][CH:29]([N:2]2[CH2:3][CH2:4][CH:5]([N:8]3[C@@H:16]4[C@H:11]([CH2:12][CH2:13][CH2:14][CH2:15]4)[CH2:10][C:9]3=[O:17])[CH2:6][CH2:7]2)[CH2:30][CH2:31]1)=[O:25]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
To a solution of (3aR,7aS)-1-piperidin-4-yloctahydro-2H-indol-2-one hydrochloride (70 mg, 0.27 mmol) in MeOH (4 mL) was added sodium methoxide (62 μl, 0.27 mmol) followed by 1-(2-methylbenzoyl)piperidin-4-one (60 mg, 0.27 mmol) and the mixture stirred at room temperature for 10 minutes. A solution containing sodium cyanoborohydride (28 mg, 0.41 mmol) and zinc chloride (18 mg, 0.13 mmol) in MeOH (1 mL) was then added and the mixture stirred at room temperature overnight. The reaction was quenched with water and solvents were removed under reduced pressure. The mixture was diluted in dichloromethane (30 mL) and 1N NaOH (7 mL) was added. The phases were separated and aqueous phase was extracted with dichloromethane (2×20 mL). The combined organic phases were dried and concentrated in vacuo. The crude compound was purified by high pH prep LCMS (40-60%) to provide the title compound as a white solid (37 mg, 37%). 1H NMR (400 MHz, CHLOROFORM-D): δ ppm 1.12-1.41 (m, 5H), 1.42-1.54 (m, 1H), 1.54-1.70 (m, 4H), 1.70-1.99 (m, 7H), 2.11-2.39 (m, 4H), 2.23 (s, 3H), 2.39-2.55 (m, 1H), 2.72 (t, J=12.50 Hz, 1H), 2.78-3.07 (m, 4H), 3.48 (d, J=12.11 Hz, 1H), 3.83-4.01 (m, 1H), 4.80 (d, J=12.50 Hz, 1H), 7.01-7.28 (m, 4H). MS (M+1): 424.2
後処理
- additionwas then added
- stirringthe mixture stirred at room temperature overnight
- customThe reaction was quenched with water and solvents
- customwere removed under reduced pressure
- additionThe mixture was diluted in dichloromethane (30 mL)
- addition1N NaOH (7 mL) was added
- customThe phases were separated
- extractionaqueous phase was extracted with dichloromethane (2×20 mL)
- customThe combined organic phases were dried
- concentrationconcentrated in vacuo
- customThe crude compound was purified by high pH prep LCMS (40-60%)
出典と根拠
- ORDレコード
- ord-02ee912a8a5149c0a800db6a1aaa42b3
- 出典データセット
- uspto-grants-2011_06
- 特許番号
- US07956069B2
反応ノート
読み込み中…